Instrument Inactif

Communiqués Renovacor, Inc.

Actions

RCOR

US75989E1064

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - OFIX, LMST, PFHD, RCOR	17/11/22	PR
RENOVACOR, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	10/11/22	AQ
RENOVACOR, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	14/10/22	AQ
Renovacor Announces Upcoming Presentation at the 29th European Society of Gene and Cell Therapy Congress	11/10/22	AQ
Renovacor Announces Upcoming Presentation at the 29th European Society of Gene & Cell Therapy Congress	10/10/22	BU
Renovacor Announces Upcoming Presentation at Keystone Symposia's Heart Failure, Mechanisms and Therapies Conference	27/09/22	AQ
Renovacor Announces Upcoming Presentation at Keystone Symposia’s Heart Failure: Mechanisms and Therapies Conference	26/09/22	BU
RENOVACOR, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22/09/22	AQ
Shareholder Alert: Ademi LLP investigates whether Renovacor, Inc. has obtained a Fair Price in its transaction with Rocket Pharmaceuticals, Inc.	21/09/22	PR
RENOVACOR, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	20/09/22	AQ
SHAREHOLDER ALERT: Weiss Law Investigates Renovacor, Inc.	20/09/22	PR
RCOR STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Renovacor, Inc. Is Fair to Shareholders	20/09/22	BU
Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene Therapy	20/09/22	BU
Renovacor : Reports Second Quarter 2022 Financial Results and Provides Corporate Update - Form 8-K	08/08/22	PU
RENOVACOR, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	08/08/22	AQ
Renovacor Reports Second Quarter 2022 Financial Results and Provides Corporate Update	08/08/22	BU
RENOVACOR, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	08/08/22	AQ
RENOVACOR, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	12/07/22	AQ
Renovacor Announces Pipeline Expansion with New Research Program for Multiple Genetic Segments of Arrhythmogenic Cardiomyopathy	12/07/22	BU
RENOVACOR, INC. Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K/A)	24/06/22	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Renovacor, Inc.

Actions

RCOR

US75989E1064

Communiqués

Filtres